Modified-Release Preparations Containing Oxcarbazepine and Derivatives Thereof
Supernus Pharmaceuticals, Inc.
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 10 of these applications claim priority to application 60/794,837, filed Apr 26, 2006. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 7,722,898 | Modified-Release Preparations Containing Oxcarbazepine and Derivatives Thereof In force · High confidence | Supernus Pharmaceuticals, Inc. | In force | High confidence | ||
| US 8,821,930 | Modified Release Preparations Containing Oxcarbazepine and Derivatives Thereof In force · Medium confidence | Supernus Pharmaceuticals, Inc. | In force | Medium confidence | ||
| US 9,119,791 | Modified Release Preparations Containing Oxcarbazepine and Derivatives Thereof In force · Medium confidence | Supernus Pharmaceuticals, Inc. | In force | Medium confidence | ||
| US 9,119,792 | Modified Release Preparations Containing Oxcarbazepine and Derivatives Thereof In force · Medium confidence | Supernus Pharmaceuticals, Inc. | In force | Medium confidence | ||
| US 9,351,975 | Modified Release Preparations Containing Oxcarbazepine and Derivatives Thereof In force · Medium confidence | Supernus Pharmaceuticals, Inc. | In force | Medium confidence | ||
| US 9,370,525 | Modified Release Preparations Containing Oxcarbazepine and Derivatives Thereof In force · Medium confidence | Supernus Pharmaceuticals, Inc. | In force | Medium confidence | ||
| US 9,855,278 | Modified Release Preparations Containing Oxcarbazepine and Derivatives Thereof In force · Medium confidence | Supernus Pharmaceuticals, Inc. | In force | Medium confidence | ||
| US 10,220,042 | Modified Release Preparations Containing Oxcarbazepine and Derivatives Thereof In force · Medium confidence | Supernus Pharmaceuticals, Inc. | In force | Medium confidence | ||
| US 11,166,960 | Modified Release Preparations Containing Oxcarbazepine and Derivatives Thereof In force · Medium confidence | Supernus Pharmaceuticals, Inc. | In force | Medium confidence | ||
| US 11,896,599 | Modified Release Preparations Containing Oxcarbazepine and Derivatives Thereof In force · Medium confidence | Supernus Pharmaceuticals, Inc. | In force | Medium confidence | ||
| 2 more patents in this group · Pro | ||||||
10 of 12 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 12, including 10 expiring within the 18 months from Nov 18, 2026.
10 of these are in force and held by Supernus Pharmaceuticals, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.